As a new quarter began this week, we used the volatility to add shares to two of our model portfolio positions.
The stock is trading lower this afternoon, along with the rest of the biotech sector, but we remain bullish on the company's outlook.
We are taking added measures to check in and see how it's going.
The stock is trading lower on management's guidance cut, but we have confidence that the company is in the early stages of a turnaround.
We used the volatility this week to add to six of our model portfolio positions, and we also closed out one other holding.
It is important to use wider scales and make smaller purchases when buying.
Though shares of Extreme Networks have declined this week, we expect the company to deliver solid earnings growth over the next few quarters.
Volatility ruled the first quarter of 2014, but dividend-paying stocks continued to generate steady gains for investors.
Though the stock is down from its recent highs, we believe the company will announce more pharmaceutical partnerships soon.
We are taking advantage of today's selloff to add shares to Martha Stewart Living, Pacific Sunwear, TherapeuticsMD and Yamana Gold and to exit our SunOpta position.